ERBB2 and breast carcinoma: The HER2+ BC do not represent a subtype itself, but are instead dispersed along the whole breast cancer spectrum, from hormone receptor-positive luminal to hormone receptor-negative basal phenotype, with genome variations accordingly to these phenotypes and incidentally defined by a specific gene amplification.